PMC:7299399 / 23466-23789
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T105 | 207-214 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T81 | 70-79 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T82 | 160-168 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T237 | 38-39 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T147 | 114-125 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T148 | 207-214 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T149 | 277-286 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98 | 81-320 | Sentence | denotes | Vaccine candidates based in this application have previously been designed for SARS-CoV with high stability.72,73 Recombinant-protein vaccines and inactivated vaccines are safer but might require adjuvants to increase their immunogenicity. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 347 | 160-168 | Species | denotes | SARS-CoV | Tax:694009 |
| 351 | 70-79 | Disease | denotes | infection | MESH:D007239 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-26513244-158495 | 189-191 | 26513244 | denotes | 72 |
| 32519842-25609816-158496 | 192-194 | 25609816 | denotes | 73 |